Vasoactive intestinal peptide (VIP) induces c-fos expression in LNCaP prostate cancer cells through a mechanism that involves Ca2+ signalling. Implications in angiogenesis and neuroendocrine differentiation

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1744, Issue 2, 2005, Pages 224-233

  Collado, Beatriz ^a   Sánchez, María G ^a   Díaz Laviada, Inés ^a   Prieto, Juan C ^a   Carmena, María J ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

c fos; Ca2+; cAMP; Prostate cancer; VEGF; VIP receptor

Indexed keywords

CALCIUM ION; CURCUMIN; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC GMP; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FURA 2; MESSENGER RNA; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROTEIN C FOS; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; VASCULOTROPIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANGIOGENESIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CANCER CELL CULTURE; CHELATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; ONCOGENE C FOS; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CALCIUM; CALCIUM SIGNALING; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHELATING AGENTS; CYCLIC AMP; DRUG INTERACTIONS; EGTAZIC ACID; GENE EXPRESSION REGULATION; HUMANS; ISOQUINOLINES; MALE; NEUROPEPTIDES; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-FOS; RNA, MESSENGER; SULFONAMIDES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASOACTIVE INTESTINAL PEPTIDE;

EID: 20444374739     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2005.04.009     Document Type: Article

References (40)

1. M. Laburthe, and A. Couvineau Molecular pharmacology and structure of VPAC receptors for VIP and PACAP Regul. Pept. 108 2002 165 173
2. M.J. Carmena, and J.C. Prieto Cyclic AMP-stimulating effect of vasoactive intestinal peptide in isolated epithelial cells of rat ventral prostate Biochim. Biophys. Acta 463 1983 414 418
3. R.M. Solano, M.J. Carmena, I. Carrero, S. Cavallaro, F. Roman, C. Hueso, S. Travali, N. Lopez-Fraile, L.G. Guijarro, and J.C. Prieto Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate Endocrinology 137 1996 2815 2822
4. N.N. Huang, D.J. Wang, and L.A. Heppel Role of adenosine 3′:5′-monophosphate-dependent protein kinase and cAMP levels in ATP-dependent mitogenesis in Swiss 3T3 cells J. Biol. Chem. 269 1994 548 555
5. I. Langer, P. Vertongen, J. Perret, M. Waelbroeck, and P. Robberecht A small sequence in the third intracellular loop of the VPAC(1) receptor is responsible for its efficient coupling to the calcium effector Mol. Endocrinol. 16 2002 1089 1096
6. 16 Cell Calcium 30 2001 229 234
7. W.I. DeHaven, and J. Cuevas VPAC receptor modulation of neuroexcitability in intracardiac neurons: dependence on intracellular calcium mobilization and synergistic enhancement by PAC1 receptor activation J. Biol. Chem. 279 2004 40609 40621
8. H. Kamaishi, T. Heñido, and T. Suzuki Multiple signal pathways coupling VIP and PACAP receptors to calcium channels in hamster submandibular ganglion neurons Auton. Neurosci. 111 2004 15 26
9. T.W. Moody, J.M. Hill, and R.T. Jensen VIP as a trophic factor in the CNS and cancer cells Peptides 24 2003 163 177
10. B. Collado, I. Gutierrez-Cañas, N. Rodriguez-Henche, J.C. Prieto, and M.J. Carmena Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells Regul. Pept. 119 2004 69 75
11. M.G. Juarranz, O. Bolaños, I. Gutiérrez-Cañas, E.A. Lerner, P. Robberecht, M.J. Carmena, J.C. Prieto, and N. Rodríguez-Henche Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptors Cell. Signal. 13 2001 887 894
12. I. Gutiérrez-Cañas, N. Rodríguez-Henche, O. Bolaños, M.J. Carmena, J.C. Prieto, and M.G. Juarranz VIP and PACAP are autocrine factors that protect the androgen-independent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawal Br. J. Pharmacol. 139 2003 1050 1058
13. T. Iwata, O. Ukimura, M. Inaba, M. Kojima, K. Kumamoto, H. Ozawa, M. Kawata, and T. Miki Immunohistochemical studies on the distribution of nerve fibers in the human prostate with special reference to the anterior fibromuscular stroma Prostate 48 2001 242 247
14. A. Plonowski, J.L. Varga, A.V. Schally, M. Krupa, K. Groot, and G. Halmos Inhibition of PC-3 human prostate cancers by analogs of growth hormone-releasing hormone (GH-RH) endowed with vasoactive intestinal peptide (VIP) antagonistic activity Int. J. Cancer 98 2002 624 629
15. E. Deutsch, L. Maggiorella, P. Eschwege, J. Bourhis, J.C. Soria, and B. Abdulkarim Environmental, genetic, and molecular features of prostate cancer Lancet Oncol. 5 2004 303 313
16. M.G. Juarranz, P. De Neef, and P. Robberecht Vasoactive intestinal polypeptide receptor VPAC(1) subtype is predominant in rat prostate membranes Prostate 41 1999 1 6
17. Y.C. Jang, L.S. Kao, and F.F. Wang Involvement of Ca2+ signalling in the vasoactive intestinal peptide and 8-Br-cAMP induction of c-fos mRNA expression Cell. Signal. 10 1998 27 34
18. H. Schafer, J. Zheng, F. Gundlach, R. Gunther, and W.E. Schmidt PACAP stimulates transcription of c-Fos and c-Jun and activates the AP-1 transcription factor in rat pancreatic carcinoma cells Biochem. Biophys. Res. Commun. 221 1996 111 116
19. R. Eferl, and E.F. Wagner AP-1: a double-edged sword in tumorigenesis Nat. Rev., Cancer 3 2003 859 868
20. E.R. Hahm, Y.S. Gho, S. Park, C. Park, K.W. Kim, and C.H. Yang Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis Biochim. Biophys. Res. Commun. 321 2004 337 344
21. N.S. Levy, M.A. Goldberg, and A.P. Levy Sequencing of the human vascular endothelial growth factor (VEGF) 3′ untranslated region (UTR): conservation of five hypoxia-inducible RNA-protein binding sites Biochim. Biophys. Acta 1352 1997 167 173
22. J.T. Chang, I.H. Chen, C.T. Liao, H.M. Wang, Y.M. Hsu, K.F. Hung, C.J. Lin, L.L. Hsieh, and A.J. Cheng A reverse transcription comparative real-time PCR method for quantitative detection of angiogenic growth factors in head and neck cancer patients Clin. Biochem. 35 2002 591 596
23. N.J. Mabjeesh, M.T. Willard, C.E. Frederickson, H. Zhong, and J.W. Simons Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3′-kinase/protein kinase B in prostate cancer cells Clin. Cancer Res. 9 2003 2416 2425
24. G. Grynkiewicz, M. Poenie, and R.Y. Tsien A new generation of Ca2+ indicators with greatly improved fluorescence properties J. Biol. Chem. 260 1985 3440 3450
25. T. Bjoro, B.C. Ostberg, O. Sand, J. Gordeladze, J.G. Iversen, P.A. Torjesen, K.M. Gautvik, and E. Haug Vasoactive intestinal peptide and peptide with N-terminal histidine and C-terminal isoleucine increase prolactin secretion in cultured rat pituitary cells (GH4C1) via a cAMP-dependent mechanism which involves transient elevation of intracellular Ca2+ Mol. Cell. Endocrinol. 49 1987 119 128
26. N. Hayez, I. Harfi, R. Lema-Kisoka, M. Svoboda, F. Corazza, and E. Sariban The neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) modulate several biochemical pathways in human leukemic myeloid cells J. Neuroimmunol. 149 2004 167 181
27. J.H. Lin, Y.C. Jang, D.C. Wen, and F.F. Wang Synergistic activation of cAMP and calcium on cAMP-response-element-mediated gene expression in GH3 pituitary tumor cells Cell. Signal. 8 1996 111 115
28. M. Udawela, D.L. Hay, and P.M. Sexton The receptor activity modifying protein family of G protein coupled receptor accessory proteins Semin. Cell Dev. Biol. 15 2004 299 308
29. G. Mazzocchi, L.K. Malendowicz, A. Ziolkowska, R. Spinazzi, P. Rebuffat, F. Aragona, E. Ferrazzi, P.P. Parnigotto, and G.G. Nussdorfer Adrenomedullin (AM) and AM receptor type 2 expression is up-regulated in prostate carcinomas (PC), and AM stimulates in vitro growth of a PC-derived cell line by enhancing proliferation and decreasing apoptosis rates Int. J. Oncol. 25 2004 1781 1787
30. A. Christopoulos, G. Christopoulos, M. Morfis, M. Udawela, M. Laburthe, A. Couvineau, K. Kuwasako, N. Tilakaratne, and P.M. Sexton Novel receptor partners and function of receptor activity-modifying proteins J. Biol. Chem. 278 2003 3293 3297
31. M.J. Berridge Inositol trisphosphate and calcium signalling Nature 361 1993 315 325
32. K. Cole, and E. Kohn Calcium-mediated signal transduction: biology, biochemistry, and therapy Cancer Metastasis Rev. 13 1994 31 44
33. A.R. Means Calcium, calmodulin and cell cycle regulation FEBS Lett. 347 1994 1 4
34. E.C. Kohn, R. Alessandro, J. Spoonster, R.P. Wersto, and L.A. Liotta Angiogenesis: role of calcium-mediated signal transduction Proc. Natl. Acad. Sci. U. S. A. 92 1995 1307 1311
35. P. Nicotera, B. Zhivotovsky, and S. Orrenius Nuclear calcium transport and the role of calcium in apoptosis Cell Calcium 16 1994 279 288
36. M.J. Berridge, M.D. Bootman, and P. Lipp Calcium-A life and death signal Nature 395 1998 645 648
37. G. Powis, and D. Phil Inhibitors of phosphatidylinositol signalling as antiproliferative agents Cancer Metastasis Rev. 13 1994 91 103
38. F. Vanden Abeele, Y. Shuba, M. Roudbaraki, L. Lemonnier, K. Vanoverberghe, P. Mariot, R. Skryma, and N. Prevarskaya Store-operated Ca2+ channels in prostate cancer epithelial cells: function, regulation, and role in carcinogenesis Cell Calcium 33 2003 357 373
39. K. Vanoverberghe, F. Vanden Abeele, P. Mariot, G. Lepage, M. Roudbaraki, J.L. Bonnal, B. Mauroy, Y. Shuba, R. Skryma, and N. Prevarskaya Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells Cell Death Differ. 11 2004 321 330
40. C.N. Sternberg Highlights of contemporary issues in the medical management of prostate cancer Crit. Rev. Oncol./Hematol. 43 2002 105 121